🕒 Monday 2 February 2026 Mon, 2 Feb 2026

Mamba Exploration Limited has inked a deal to acquire a majority interest in the underexplored Meeka East Gold Project in Western Australia’s prolific Murchison Goldfield, backed by a $2 million capital raise to fund early-stage exploration.

Mamba Exploration Limited has agreed to acquire a 70% interest in the Meeka East Gold Project in Western Australia’s Murchison Goldfield, supported by a $2 million capital raise to fund exploration activities.

Pursuit Minerals Limited has had its trading suspension lifted following the release of its Pre-Feasibility Study and a capital raising announcement, signaling renewed investor interest.

Estrella Resources has entered a $2 million underwriting agreement to support the exercise of its listed options, ensuring capital inflow ahead of the December expiry.

Pursuit Minerals has delivered a compelling Pre-Feasibility Study for its Rio Grande Sur lithium project in Argentina, confirming strong economics and a maiden Ore Reserve. The company also secured a A$7 million capital raise to advance development.

Arena REIT has announced its December 2025 quarter distribution of 4.8125 cents per stapled security, reflecting steady income from its social infrastructure portfolio. The distribution includes components relevant for tax purposes, underscoring the REIT’s ongoing compliance and investor transparency.

Arcadia Minerals Limited has had its trading suspension lifted following a significant announcement about a proposed capital raising and an earn-in agreement on the Swanson Tantalum Mine.

Arcadia Minerals has secured a binding term sheet with Hongkong Xinhai Mining Services, granting Xinhai an exclusive option to advance the Swanson Tantalum Project in Namibia towards production through a strategic partnership and investment.

Actinogen Medical has raised approximately $17 million through a share placement and purchase plan to fund the completion of its pivotal XanaMIA Alzheimer’s trial following encouraging interim results.

First Au Limited has successfully raised $5.6 million in a placement to fund exploration at its Gimlet Gold Project and expand its Western Australian gold strategy.

FireFly Metals has agreed to sell its Ontario gold assets to Bellavista Resources for up to A$86.1 million in shares and performance rights, unlocking value for shareholders while focusing on its copper-gold growth strategy.

FireFly Metals has agreed to sell its Ontario gold assets, including a 70% stake in the Pickle Crow Project, to Bellavista Resources for up to A$86.1 million in scrip. FireFly shareholders will receive Bellavista shares, maintaining exposure to the assets while FireFly focuses on its copper-gold ambitions.

First Au Limited has reported strong initial assay results from its Phase 3 drilling at the Gimlet Gold Project, confirming high-grade gold mineralisation and setting the stage for a resource upgrade.

Cyprium Metals has completed the first tranche of a A$36 million placement, positioning itself to fast-track exploration and production growth at its Nifty Copper Complex in Western Australia.

Kingfisher Mining’s December 2025 drilling at the Copper Blow IOCG prospect near Broken Hill confirms strong, continuous high-grade copper-gold mineralisation, setting the stage for a maiden resource estimate.

Hydrix Limited has amended its quarterly cash flow report, revealing stronger customer receipts and a stable cash position supported by robust financing facilities.

PYC Therapeutics has launched a A$653 million capital raising to fund the clinical advancement of four RNA-based drug candidates targeting genetic diseases with significant unmet needs. The raise extends the company’s cash runway to 2030, supporting key clinical milestones and a transition to commercialisation.

PYC Therapeutics has launched a substantial $653 million equity raise to fund clinical trials for four promising drug candidates targeting genetic diseases. This capital injection aims to advance the company’s pipeline through critical human efficacy milestones.

Cyclopharm has reported a record $32.3 million in operating revenue for FY2025, led by explosive growth in its U.S. Technegas market following FDA approval. The company reaffirms its ambitious target of 250–300 U.S. installations by mid-2026 amid strong clinical momentum.

Kairos Minerals has been granted a 21-year mining lease for its 1.4 million ounce Mt York Gold Project in Western Australia, marking a pivotal step towards advancing the project into production.

Axel REE Limited's latest magnesium sulphate leach tests at the Paraíso target confirm robust rare earth grades and a magnet-rich basket, underpinning a modular in-situ leach development at the Caladão Project in Brazil.

Neurotech International has secured ethics approval to launch its Beyond Harmony Phase 3 clinical trial of NTI164 for autism spectrum disorder, marking a key step toward regulatory submissions in Australia and the US.

EV Resources has launched its first-ever diamond drilling program at the Los Lirios Antimony Project in Mexico, aiming to unlock the potential of a historically high-grade mineral system. The company is also refining assay methods to ensure accurate measurement of antimony content.

The ASX has suspended trading in Aspermont Limited, Koba Resources, and WA Kaolin due to their failure to lodge required periodic reports on time. The suspension may be lifted if the companies submit their reports promptly.